Prot #AB-PSP-002: A Multicenter, Prospective, Biomarker-Result-Blinded Observational Study Evaluating Immunoassay Measurements of Pancreatic Stone Protein Performed on Abionic’s abioSCOPE® Device with the PSP Assay on ICU Patients at Risk of Sepsis as an

Project: Research project

Project Details

StatusActive
Effective start/end date2/17/202/17/22

Funding

  • Abionic SA (Prot #AB-PSP-002)